ZF874
ZF-0101
Phase 1 small_molecule terminated
Quick answer
ZF874 for Alpha1 Anti-Trypsin Deficiency is a Phase 1 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Centessa Pharmaceuticals plc
- Indication
- Alpha1 Anti-Trypsin Deficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated